APA aipamena

Nishino, M., Dahlberg, S. E., Fulton, L. E., Digumarthy, S. R., Hatabu, H., Johnson, B. E., & Sequist, L. V. (2016). Volumetric tumor response and progression in EGFR-mutant NSCLC patients treated with erlotinib or gefitinib. Acad Radiol.

Chicago Style aipamena

Nishino, Mizuki, Suzanne E. Dahlberg, Linnea E. Fulton, Subba R. Digumarthy, Hiroto Hatabu, Bruce E. Johnson, and Lecia V. Sequist. "Volumetric Tumor Response and Progression in EGFR-mutant NSCLC Patients Treated With Erlotinib or Gefitinib." Acad Radiol 2016.

MLA aipamena

Nishino, Mizuki, et al. "Volumetric Tumor Response and Progression in EGFR-mutant NSCLC Patients Treated With Erlotinib or Gefitinib." Acad Radiol 2016.